Open AccessFeasibility of magnetoencephalographic source imaging in patients with thalamic deep brain stimulation for epilepsy
Author(s) -
Wennberg Richard,
Campo J. Martin,
Shampur Nat,
Rowland Nathan C.,
Valiante Taufik,
Lozano Andres M.,
Garcia Dominguez Luis
Publication year - 2017
Publication title -
epilepsia open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.247
H-Index - 16
ISSN - 2470-9239
DOI - 10.1002/epi4.12027
Subject(s) - magnetoencephalography , epilepsy , deep brain stimulation , neuroscience , stimulation , thalamic stimulator , thalamus , neuroimaging , medicine , psychology , electroencephalography , disease , parkinson's disease
Summary Source localization of interictal spikes in patients with medically refractory epilepsy is the most common clinical application of magnetoencephalography ( MEG ). In recent decades, many patients with intractable epilepsy have been treated with various forms of neurostimulation, including thalamic deep brain stimulation ( DBS ). Patients with suboptimal seizure control after DBS might in some cases benefit from further investigations for resective epilepsy surgery, including MEG source imaging ( MSI ). We sought to determine the feasibility and accuracy of MSI in the setting of active thalamic DBS . Simultaneous EEG / MEG was obtained in a patient using an Elekta 306‐channel MEG system, with high‐frequency (100 Hz) DBS of the thalamic anterior nuclei cycling between on and off states. Magnetic artifacts associated with the DBS apparatus were successfully suppressed using the spatiotemporal signal space separation (t SSS ) method. Electrical stimulation artifact was removed by standard digital low‐pass filtering. Dipole source modeling results for spike foci in frontal and posterior temporal regions were comparable between stimulation on and stimulation off states, and the source solutions corresponded well to the localization of spikes documented by intracranial EEG . MSI is thus feasible and source solutions can be accurate when performed in patients with active thalamic DBS for epilepsy.